These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 32296020)

  • 1. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.
    Gao L; Zhong X; Jin J; Li J; Meng XM
    Signal Transduct Target Ther; 2020 Feb; 5(1):9. PubMed ID: 32296020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs in kidney injury and repair.
    Liu Z; Wang Y; Shu S; Cai J; Tang C; Dong Z
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C177-C188. PubMed ID: 30969781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming Growth Factor-β in the Acute Kidney Injury to Chronic Kidney Disease Transition.
    Gewin LS
    Nephron; 2019; 143(3):154-157. PubMed ID: 31039574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
    Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the transition of acute kidney injury to chronic kidney disease: Potential mechanisms and future perspectives.
    Ogbadu J; Singh G; Aggarwal D
    Eur J Pharmacol; 2019 Dec; 865():172711. PubMed ID: 31589870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.
    He L; Wei Q; Liu J; Yi M; Liu Y; Liu H; Sun L; Peng Y; Liu F; Venkatachalam MA; Dong Z
    Kidney Int; 2017 Nov; 92(5):1071-1083. PubMed ID: 28890325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression.
    Li Z; Li N
    Nephron; 2021; 145(6):737-747. PubMed ID: 34419948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endoplasmic reticulum stress and autophagy in the transition from acute kidney injury to chronic kidney disease.
    Habshi T; Shelke V; Kale A; Anders HJ; Gaikwad AB
    J Cell Physiol; 2023 Jan; 238(1):82-93. PubMed ID: 36409755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
    Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
    Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling.
    Li ZL; Wang B; Lv LL; Tang TT; Wen Y; Cao JY; Zhu XX; Feng ST; Crowley SD; Liu BC
    Acta Pharmacol Sin; 2021 Dec; 42(12):2106-2119. PubMed ID: 33658705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.
    Franzin R; Stasi A; Fiorentino M; Stallone G; Cantaluppi V; Gesualdo L; Castellano G
    Front Immunol; 2020; 11():734. PubMed ID: 32457738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
    Zhang X; Agborbesong E; Li X
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.
    Tan HL; Yap JQ; Qian Q
    Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated miR-101 inhibits acute kidney injury-chronic kidney disease transition by regulating epithelial-mesenchymal transition.
    Zhao JY; Wang XL; Yang YC; Zhang B; Wu YB
    Hum Exp Toxicol; 2020 Dec; 39(12):1628-1638. PubMed ID: 32633566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of SIK1 in the transition of acute kidney injury into chronic kidney disease.
    Hu J; Qiao J; Yu Q; Liu B; Zhen J; Liu Y; Ma Q; Li Y; Wang Q; Wang C; Lv Z
    J Transl Med; 2021 Feb; 19(1):69. PubMed ID: 33588892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure.
    Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C
    FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.
    Zhao L; Han F; Wang J; Chen J
    Stem Cell Res Ther; 2019 Dec; 10(1):385. PubMed ID: 31843011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.